Volitionrx Ltd (VNRX) Stock Analysis

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NYSE MKT

Key Metrics

• Price: $0.24
• Market Cap: $32.97M
• EPS: $-0.29
• 52-Week High: $0.94
• 52-Week Low: $0.17

Market Sentiment

Volitionrx Ltd currently has a Bullish sentiment score of 0.17.

About Volitionrx Ltd

VolitionRx Limited (VNRX) is an innovative multinational epigenetics company based in Austin, Texas, dedicated to developing blood-based diagnostic tests aimed at improving cancer detection and other disease diagnoses globally. Utilizing its proprietary Nu.Q™ platform, VolitionRx focuses on creating advanced, non-invasive diagnostic solutions that seek to enhance patient outcomes through early disease detection. Positioned at the cutting edge of the expanding epigenetics market, the company i...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Volitionrx Ltd and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does VNRX pay dividends?

Volitionrx Ltd (VNRX) does not currently pay a regular dividend.

What is VNRX's market cap?

Volitionrx Ltd (VNRX) has a market capitalization of $32.97M with a current stock price of $0.24.